|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
US20040142859A1
(en)
|
2002-05-02 |
2004-07-22 |
Steffan Joan S. |
Method for treating neurodegenerative, psychiatric, and other disorders with deacetylase inhibitors
|
|
EP1390491B1
(en)
|
2001-05-02 |
2008-07-16 |
The Regents of the University of California |
Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors
|
|
US20050227915A1
(en)
|
2001-05-02 |
2005-10-13 |
Steffan Joan S |
Methods and reagents for treating neurodegenerative diseases and motor deficit disorders
|
|
WO2003032921A2
(en)
|
2001-10-16 |
2003-04-24 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
ES2532607T3
(es)
|
2002-03-04 |
2015-03-30 |
Merck Hdac Research, Llc |
Métodos de inducción de la diferenciación terminal
|
|
WO2003080864A1
(fr)
|
2002-03-26 |
2003-10-02 |
Exhonit Therapeutics Sa |
Histone deacetylase: nouvelle cible moleculaire de la neurotoxicite
|
|
AU2003226014A1
(en)
|
2002-03-28 |
2003-10-13 |
Brigham And Women's Hospital, Inc. |
Histone deacetylase inhibitors for the treatment of multiple sclerosis, amyotrophic lateral sclerosis and alzheimer's disease
|
|
ITMI20040876A1
(it)
|
2004-04-30 |
2004-07-30 |
Univ Degli Studi Milano |
Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari
|
|
US20060018921A1
(en)
|
2004-07-16 |
2006-01-26 |
Baylor College Of Medicine |
Histone deacetylase inhibitors and cognitive applications
|
|
GT200500321A
(es)
|
2004-11-09 |
2006-09-04 |
|
Compuestos y composiciones como inhibidores de proteina kinase.
|
|
CN101056632B
(zh)
*
|
2004-11-09 |
2011-12-07 |
Irm责任有限公司 |
用作蛋白激酶抑制剂的化合物和组合物
|
|
US20060135612A1
(en)
|
2004-12-17 |
2006-06-22 |
U.S. Department Of Veterans Affairs |
Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent
|
|
WO2006102557A2
(en)
|
2005-03-22 |
2006-09-28 |
The President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
|
KR20080033463A
(ko)
|
2005-07-27 |
2008-04-16 |
유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. |
단백질 미스폴딩을 보정하는 작은 화합물 및 그의 용도
|
|
EP1937236A2
(en)
|
2005-09-07 |
2008-07-02 |
Braincells, Inc. |
Modulation of neurogenesis by hdac inhibition
|
|
WO2007049262A1
(en)
|
2005-10-27 |
2007-05-03 |
Berand Limited |
Methods and compositions for the promotion of neuronal growth and the treatment of asociality and affective disorders
|
|
AU2006312083A1
(en)
|
2005-11-03 |
2007-05-18 |
Merck Sharp & Dohme Corp. |
Histone deacetylase inhibitors with aryl-pyrazolyl motifs
|
|
US20070207950A1
(en)
|
2005-12-21 |
2007-09-06 |
Duke University |
Methods and compositions for regulating HDAC6 activity
|
|
GB0612273D0
(en)
|
2006-06-21 |
2006-08-02 |
Friedrich Miescher Inst For Bi |
Prevention of muscle atrophy
|
|
US8088951B2
(en)
|
2006-11-30 |
2012-01-03 |
Massachusetts Institute Of Technology |
Epigenetic mechanisms re-establish access to long-term memory after neuronal loss
|
|
WO2008073733A1
(en)
|
2006-12-08 |
2008-06-19 |
Kalypsys, Inc. |
Salts of inhibitors of histone deacetylase for the treatment of disease
|
|
EP2120910A2
(en)
|
2006-12-15 |
2009-11-25 |
Novartis Ag |
Heterocycle compounds and methods of use thereof
|
|
WO2008126932A2
(en)
|
2007-04-09 |
2008-10-23 |
Riken |
Epigenetical regulation of brain plasticity
|
|
CA2690191C
(en)
|
2007-06-27 |
2015-07-28 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
WO2009027349A2
(en)
|
2007-08-24 |
2009-03-05 |
Oryzon Genomics Sa |
Treatment and prevention of neurodegenerative diseases
|
|
US20090136461A1
(en)
|
2007-11-28 |
2009-05-28 |
Moon Suk Kim |
Neuronal differentiation method of adult stem cells using small molecules
|
|
AU2013203735A1
(en)
*
|
2007-12-04 |
2013-05-02 |
F. Hoffmann-La Roche Ag |
Isoxazolo-pyridine derivatives
|
|
BR112012015129A2
(pt)
|
2009-12-22 |
2019-09-24 |
Celgene Corp |
"composto, composição farmacêutica e método para tratar, controlar ou prevenir uma doença ou distúrbio"
|
|
US8981084B2
(en)
|
2010-01-13 |
2015-03-17 |
Tempero Pharmaceuticals, Inc. |
Oxadiazole HDAC inhibitors
|
|
CA2787018A1
(en)
|
2010-01-13 |
2011-07-21 |
Tempero Pharmaceuticals, Inc. |
Inhibitors of histone deacetylase (hdac) enzymes
|
|
WO2012018499A2
(en)
|
2010-08-05 |
2012-02-09 |
Acetylon Pharmaceuticals |
Specific regulation of cytokine levels by hdac6 inhibitors
|
|
EP2624832B1
(en)
|
2010-10-08 |
2017-09-27 |
Vib Vzw |
Hdac inhibitors to treat charcot-marie-tooth disease
|
|
WO2012058128A2
(en)
|
2010-10-28 |
2012-05-03 |
Merck Sharp & Dohme Corp. |
Caprolactam mglur5 receptor modulators
|
|
DK2680694T3
(en)
|
2011-02-28 |
2019-03-25 |
Biomarin Pharm Inc |
HISTONDEACETYLASE INHIBITORS
|
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
US8957066B2
(en)
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
|
JP6240063B2
(ja)
|
2011-04-28 |
2017-11-29 |
ザ ブロード インスティテュート， インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
US20140235649A1
(en)
|
2011-05-24 |
2014-08-21 |
Lixte Biotechnology, Inc. |
Use of phosphatase inhibitors or histone deacetylase inhibitors to treat diseases characterized by loss of protein function
|
|
WO2013006408A1
(en)
|
2011-07-01 |
2013-01-10 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
|
JP6047563B2
(ja)
|
2011-07-08 |
2016-12-21 |
ノバルティス アーゲー |
新規トリフルオロメチル−オキサジアゾール誘導体および疾患の治療におけるその使用
|
|
WO2013009827A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009810A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
WO2013009830A1
(en)
|
2011-07-13 |
2013-01-17 |
Tempero Pharmaceuticals, Inc. |
Methods of treatment
|
|
US9512083B2
(en)
|
2011-07-20 |
2016-12-06 |
The General Hospital Corporation |
Histone deacetylase 6 selective inhibitors for the treatment of bone disease
|
|
WO2013066839A2
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066838A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066835A2
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
WO2013066833A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods to inhibit histone deacetylase (hdac) enzymes
|
|
WO2013066831A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
|
JP5966014B2
(ja)
|
2011-11-28 |
2016-08-10 |
ノバルティス アーゲー |
新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用
|
|
WO2013149091A1
(en)
|
2012-03-29 |
2013-10-03 |
The Regents Of The University Of Colorado, A Body Corporate |
Composition and method for treating neurodegenerative disease
|
|
EP2841067A4
(en)
|
2012-04-25 |
2016-04-13 |
Univ California |
MEDICINAL SCREENING PLATFORM FOR THE RETT SYNDROME
|
|
WO2014006114A1
(en)
|
2012-07-05 |
2014-01-09 |
Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute For Biomedical Research |
New treatment for neurodegenerative diseases
|
|
CN104894060B
(zh)
|
2014-03-03 |
2018-11-06 |
中国科学院上海生命科学研究院 |
诱导体细胞转分化为神经干细胞的方法及其应用
|
|
MX2016011833A
(es)
|
2014-03-12 |
2017-03-29 |
Chong Kun Dang Pharmaceutical Corp |
Nuevos compuestos como inhibidores de histona desacetilasa 6 y composiciones farmaceuticas que los comprenden.
|
|
EP3187497A4
(en)
|
2014-08-26 |
2018-02-07 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
JPWO2016039398A1
(ja)
|
2014-09-09 |
2017-06-15 |
国立大学法人大阪大学 |
含窒素複素環誘導体、神経保護剤及び癌治療用医薬組成物
|
|
EA201792673A1
(ru)
|
2015-02-02 |
2018-04-30 |
Форма Терапьютикс, Инк. |
3-арил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac
|
|
JPWO2017014170A1
(ja)
*
|
2015-07-17 |
2018-04-26 |
武田薬品工業株式会社 |
複素環化合物
|
|
EA033198B1
(ru)
*
|
2015-07-17 |
2019-09-30 |
Такеда Фармасьютикал Компани Лимитед |
Оксадиазольные производные, пригодные в качестве ингибиторов hdac
|
|
HUE048534T2
(hu)
|
2015-07-27 |
2020-07-28 |
Chong Kun Dang Pharmaceutical Corp |
1,3,4-oxadiazol-szulfamid-származékok hiszton deacetiláz 6 inhibitorként és ezt tartalmazó gyógyszerkészítmény
|
|
RU2697665C1
(ru)
|
2015-07-27 |
2019-08-16 |
Чонг Кун Данг Фармасьютикал Корп. |
Производные 1,3,4-оксадиазолсульфонамида в качестве ингибиторов деацетилазы гистонов 6 и фармацевтическая композиция, содержащая их
|
|
CN108026056B
(zh)
|
2015-07-27 |
2021-08-03 |
株式会社钟根堂 |
作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑酰胺衍生物化合物及其药物组合物
|
|
BR112018002304B1
(pt)
|
2015-08-04 |
2023-12-19 |
Chong Kun Dang Pharmaceutical Corp |
Compostos de derivado de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos
|
|
WO2017033946A1
(ja)
|
2015-08-25 |
2017-03-02 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2017065473A1
(en)
|
2015-10-12 |
2017-04-20 |
Chong Kun Dang Pharmaceutical Corp. |
Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
|
|
WO2017222952A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3- heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
US20180016314A1
(en)
|
2016-07-12 |
2018-01-18 |
Children's Hospital Medical Center |
Treatment of disease via transcription factor modulation
|
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
|
AU2018274176A1
(en)
|
2017-05-24 |
2020-01-16 |
Zevra Denmark A/S |
Heat shock protein inducers and frontotemporal disorders
|
|
CA3071825A1
(en)
|
2017-07-31 |
2019-02-07 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
EP3664789B1
(en)
|
2017-08-09 |
2023-11-22 |
Children's Hospital Medical Center |
Methods for treating diseases and nerve injury
|
|
EP3664828A1
(en)
|
2017-08-10 |
2020-06-17 |
Friedrich Miescher Institute for Biomedical Research |
Hdac6 and protein aggregation
|
|
JP6910984B2
(ja)
|
2018-03-30 |
2021-07-28 |
株式会社ホンダアクセス |
脱出ハンマー収容具
|
|
KR102316234B1
(ko)
|
2018-07-26 |
2021-10-22 |
주식회사 종근당 |
히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
|
|
AU2019364336B2
(en)
|
2018-10-22 |
2023-11-16 |
Alumis Inc. |
TYK2 inhibitors and uses thereof
|
|
EP3919055A4
(en)
|
2019-01-30 |
2022-11-09 |
Takeda Pharmaceutical Company Limited |
HETEROCYCLIC COMPOUND
|